The Allstate Co. (NYSE:ALL) Shares Sold by Farmers Trust Co.

Farmers Trust Co. reduced its holdings in The Allstate Co. (NYSE:ALL) by 5.4% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,665 shares of the insurance provider’s stock after selling 211 shares during the quarter. Farmers Trust Co.’s holdings in Allstate were worth $707,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently modified their holdings of ALL. International Assets Investment Management LLC bought a new stake in Allstate during the fourth quarter worth approximately $14,518,000. Peoples Bank KS bought a new position in Allstate during the fourth quarter valued at about $49,000. Boltwood Capital Management boosted its stake in Allstate by 10.5% during the fourth quarter. Boltwood Capital Management now owns 7,710 shares of the insurance provider’s stock valued at $1,486,000 after buying an additional 730 shares in the last quarter. Nordea Investment Management AB grew its holdings in Allstate by 1.2% during the fourth quarter. Nordea Investment Management AB now owns 54,086 shares of the insurance provider’s stock worth $10,397,000 after acquiring an additional 631 shares during the period. Finally, GAMMA Investing LLC raised its position in Allstate by 27.2% in the fourth quarter. GAMMA Investing LLC now owns 5,070 shares of the insurance provider’s stock worth $977,000 after acquiring an additional 1,084 shares in the last quarter. Institutional investors own 76.47% of the company’s stock.

Allstate Stock Up 2.4 %

NYSE:ALL traded up $4.47 during trading hours on Wednesday, reaching $190.51. The company’s stock had a trading volume of 1,511,875 shares, compared to its average volume of 1,901,519. The company has a debt-to-equity ratio of 0.43, a current ratio of 0.40 and a quick ratio of 0.40. The company has a market cap of $50.45 billion, a price-to-earnings ratio of 12.34, a price-to-earnings-growth ratio of 1.70 and a beta of 0.52. The Allstate Co. has a one year low of $148.23 and a one year high of $209.88. The business’s 50-day moving average is $195.77 and its 200-day moving average is $185.14.

Allstate (NYSE:ALL) last issued its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $3.91 EPS for the quarter, beating analysts’ consensus estimates of $2.20 by $1.71. Allstate had a return on equity of 26.67% and a net margin of 6.77%. The business had revenue of $16.63 billion for the quarter, compared to analyst estimates of $14.57 billion. During the same quarter in the prior year, the firm posted $0.81 EPS. The firm’s revenue for the quarter was up 14.7% on a year-over-year basis. Equities research analysts predict that The Allstate Co. will post 16.26 EPS for the current year.

Allstate Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Thursday, January 2nd. Shareholders of record on Friday, November 29th were issued a dividend of $0.92 per share. This represents a $3.68 dividend on an annualized basis and a yield of 1.93%. The ex-dividend date was Friday, November 29th. Allstate’s dividend payout ratio (DPR) is 23.83%.

Wall Street Analyst Weigh In

A number of research firms recently commented on ALL. Evercore ISI upgraded shares of Allstate from an “in-line” rating to an “outperform” rating in a report on Wednesday. Jefferies Financial Group raised their price objective on Allstate from $231.00 to $267.00 and gave the stock a “buy” rating in a research note on Friday, November 8th. Piper Sandler boosted their target price on Allstate from $206.00 to $244.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 26th. BMO Capital Markets increased their price target on Allstate from $205.00 to $214.00 and gave the company an “outperform” rating in a research report on Friday, October 18th. Finally, JPMorgan Chase & Co. lifted their target price on shares of Allstate from $205.00 to $207.00 and gave the stock an “overweight” rating in a research report on Thursday, October 10th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating, fourteen have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, Allstate presently has an average rating of “Moderate Buy” and a consensus price target of $216.94.

Allstate Company Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.